Cancer

At the Kolling Institute, our cancer research aims to identify and overcome the factors that drive cancer development so that we can improve patient outcomes. We have a number of cancer research teams with different expertise, specialising in chemotherapy resistance, immunotherapies, genetics, epigenetics, diagnostic services and clinical trials. Importantly, these teams have access to an active tissue bank and the latest equipment.

Our cancer research rapidly implements laboratory findings into clinical practice and is supported by the Cancer Institute Translational Centre, Sydney Vital. By bringing together research scientists, clinicians and allied health professionals, we are able to combine innovative and cutting edge research with personalised treatment strategies for cancer patients.

Find out more about:

Bill Walsh Translational Cancer Research Laboratory

Bowel Cancer and Biomarker Research Lab

Breast Cancer Research

Cancer Genetics Laboratory

Events, News and Seminars

Common, easily accessible medication could reduce severe COVID-19 symptoms

Common, easily accessible medication could reduce severe COVID-19 symptoms

A group of blood pressure medications may hold the key to better outcomes for those with COVID-19, m..... Read more

Category: New Treatment

New research challenges long-held views about high heels and joint pain

New research challenges long-held views about high heels and joint pain

New research has produced a surprising result, indicating high heel shoes may not be a problem for t..... Read more

Category: Research Excellence

Congratulations Professor Rob Baxter

Congratulations Professor Rob Baxter

Former Kolling Institute director Professor Rob Baxter received an Order of Australia medal in the Q..... Read more

Category: Awards